首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer
【2h】

CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer

机译:CRT结合顺序VMAT增强治疗上胸食管癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The purpose of this study is to investigate the potential benefits of conformal radiotherapy (CRT) combined with a sequential volumetric‐modulated arc therapy (VMAT) boost in the treatment of upper thoracic esophageal cancer. Ten patients with upper thoracic esophageal cancer previously treated with CRT plus a sequential VMAT boost plan were replanned with CRT plus an off‐cord CRT boost plan and a full course of VMAT plan. Dosimetric parameters were compared. Results indicated that CRT plus off‐cord CRT boost was inferior in planning target volume (PTV) coverage, as indicated by the volume covered by 93% (p  =  0.05) and 95% (p  =  0.02) of the prescription dose. The full course VMAT plan was superior in conformal index (CI) and conformation number (CN), and produced the highest protection for the spinal cord. CRT plus a VMAT boost demonstrated significant advantages in decreasing the volume of the lung irradiated by a dose of 10 Gy (V10,  p  =  0.007), 13 Gy (V13,  p  =  0.003), and 20 Gy (V20,  p  =  0.001). The full course VMAT plan demonstrated the lowest volume of lung receiving a dose of 30 Gy. CRT plus a VMAT boost for upper thoracic esophageal cancer can improve the target coverage and reduce the volume of lung irradiated by an intermediate dose. This combination may be a promising treatment technique for patients with upper thoracic esophageal cancer.PACS number: 87.53.Kn, 87.55.x, 87.55.D, 87.55.dk
机译:这项研究的目的是研究保形放疗(CRT)结合顺序容积调制电弧治疗(VMAT)增强疗法在治疗上胸段食管癌中的潜在优势。十名先前接受过CRT加序贯性VMAT强化治疗的上胸食管癌患者被重新规划了CRT加无绳CRT强化方案和整个VMAT疗程。比较剂量学参数。结果表明,CRT加上体外CRT刺激在计划目标体积(PTV)覆盖率方面较差,这由处方剂量的93%(p = 0.05)和95%(p = 0.02)覆盖所表明。全程VMAT计划在保形指数(CI)和构象数(CN)方面均优越,并且对脊髓的保护作用最高。 CRT和VMAT增强显示出在减少10 Gy decreasing(V10,p = 0.007),13 Gy(V13,p = 0.003)和20 Gy(V20,p = 0.001)剂量下的肺照射量减少方面的显着优势。 。整个疗程的VMAT计划表明,接受30 Gy剂量剂量的肺量最小。 CRT加上VMAT对上胸食管癌的增强作用可以改善靶标覆盖率,并减少中等剂量照射肺的体积。这种组合对于上胸段食管癌患者可能是一种有前途的治疗技术.PACS编号:87.53.Kn,87.55.x,87.55.D,87.55.dk

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号